Renaissance Technologies - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,109
-31.2%
3,266,025
+4.9%
0.02%
-20.0%
Q2 2023$20,509
+2.9%
3,112,067
+6.0%
0.03%
+15.4%
Q1 2023$19,930
-6.7%
2,935,225
+1.6%
0.03%
-10.3%
Q4 2022$21,353
-99.9%
2,889,425
-12.3%
0.03%
-37.0%
Q3 2022$32,557,000
-17.9%
3,295,233
-9.4%
0.05%
-2.1%
Q2 2022$39,637,000
+9.2%
3,636,433
+13.3%
0.05%
+9.3%
Q1 2022$36,289,000
-28.0%
3,208,614
-0.1%
0.04%
-31.7%
Q4 2021$50,400,000
-10.4%
3,212,214
-2.1%
0.06%
-13.7%
Q3 2021$56,259,000
-21.0%
3,282,322
-0.9%
0.07%
-18.0%
Q2 2021$71,218,000
+28.6%
3,310,922
-10.2%
0.09%
+29.0%
Q1 2021$55,371,000
+5.6%
3,686,480
-7.6%
0.07%
+21.1%
Q4 2020$52,434,000
+23.9%
3,990,403
-8.9%
0.06%
+35.7%
Q3 2020$42,320,000
-12.5%
4,380,922
+3.6%
0.04%0.0%
Q2 2020$48,389,000
+21.3%
4,229,822
+9.9%
0.04%
+7.7%
Q1 2020$39,882,000
-29.6%
3,849,654
+11.5%
0.04%
-11.4%
Q4 2019$56,666,000
+33.0%
3,453,112
+7.6%
0.04%
+22.2%
Q3 2019$42,607,000
+8.1%
3,208,340
+14.7%
0.04%
+2.9%
Q2 2019$39,425,000
-16.5%
2,798,050
+9.1%
0.04%
-18.6%
Q1 2019$47,191,000
-28.1%
2,564,750
+2.1%
0.04%
-40.3%
Q4 2018$65,622,000
+39.6%
2,511,350
+22.6%
0.07%
+50.0%
Q3 2018$47,017,000
-21.2%
2,048,650
-38.3%
0.05%
+45.5%
Q2 2018$59,663,000
+115.9%
3,321,300
+102.5%
0.03%
+10.0%
Q1 2018$27,635,000
+26.7%
1,640,050
+14.3%
0.03%
+25.0%
Q4 2017$21,810,000
+0.0%
1,434,850
+17.8%
0.02%
-7.7%
Q3 2017$21,807,000
+21.8%
1,218,250
+11.0%
0.03%
+13.0%
Q2 2017$17,897,000
+36.1%
1,097,950
+16.9%
0.02%
+27.8%
Q1 2017$13,150,000
+45.1%
939,250
+65.3%
0.02%
+28.6%
Q4 2016$9,065,000
+26.1%
568,350
+31.5%
0.01%
+7.7%
Q3 2016$7,189,000
+325.4%
432,050
+186.0%
0.01%
+333.3%
Q2 2016$1,690,000
-51.5%
151,050
-63.8%
0.00%
-57.1%
Q1 2016$3,485,000
+11.0%
416,900
+23.6%
0.01%0.0%
Q4 2015$3,141,000
+73.2%
337,390
+72.9%
0.01%
+75.0%
Q1 2015$1,814,000
-35.4%
195,100
-24.0%
0.00%
-42.9%
Q3 2013$2,810,000
-1.8%
256,600
-27.5%
0.01%
-12.5%
Q2 2013$2,861,000354,1290.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders